Month: July 2024

Zahrawi Group is delighted to announce its partnership with ANF Therapy – in KSA, Qatar & Oman.

This strategic alliance elevates our portfolio with wearable transformative solutions. It reinforces our dedication to elevate standards of neuro biofrequency therapy, ANF Therapy®: safe, noninvasive, chemical-free therapy for pain relief and rehabilitation.

Zahrawi Group participated in the Precision Medicine Exhibition & Summit 2024 congress (PMES) alongside our esteemed partner, Agilent from May 8th to 9th, 2024 at Dubai World Trade Centre, United Arab Emirates.

PMES 2024 welcomed speakers from the Middle East and beyond to showcase global developments in precision medicine across borders to accelerate adaptation within the region.

The conference featured pioneering scientific insights on precision medicine, presented by respected speakers from both the MENA region and from around the globe. Agilent hosted two exclusive presentations tackling the Future in Human Genetics presented by Dr. Charbel Souaid, Ph.D, Field Application Scientist, Agilent Technologies, France, and Automation of NGS Library Preparation for Clinical Diagnostics of Rare Genetic Diseases and Cancer using Magnis presented by Dr. Hemad Yasaei, Ph.D, Head of Molecular Genomic, National Reference Laboratory, M42, Abu Dhabi, UAE.

Our participation shows our dedication to advancing personalized healthcare solutions, with the help of our partners we showcase state-of-the-art technologies and research to help shape the future of precision medicine.